The Roles of Bone Marrow-Derived Stem Cells in Coronary Collateral Growth Induced by Repetitive Ischemia

Many clinical trials have attempted to use stem cells to treat ischemic heart diseases (IHD), but the benefits have been modest. Though coronary collaterals can be a “natural bypass” for IHD patients, the regulation of coronary collateral growth (CCG) and the role of endogenous stem cells in CCG are...

Descripción completa

Detalles Bibliográficos
Autores principales: Enrick, Molly, Jamaiyar, Anurag, Ohanyan, Vahagn, Juguilon, Cody, Kolz, Christopher, Shi, Xin, Janota, Danielle, Wan, Weiguo, Richardson, Devan, Stevanov, Kelly, Hakobyan, Tatevik, Shockling, Lindsay, Diaz, Arianna, Usip, Sharon, Dong, Feng, Zhang, Ping, Chilian, William M., Yin, Liya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856468/
https://www.ncbi.nlm.nih.gov/pubmed/36672176
http://dx.doi.org/10.3390/cells12020242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856468/
https://www.ncbi.nlm.nih.gov/pubmed/36672176
http://dx.doi.org/10.3390/cells12020242

Ejemplares similares